| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Assessment of significant hepatic damage in young patients with chronic hepatitis B to initiate the antiviral treatment: The APLB score
|
Guo, Yi-Fan
|
|
|
241 |
C |
p.
|
article
|
| 2 |
Cerebrospinal fluid concentrations, viral suppression and biomarkers with long-acting cabotegravir and rilpivirine intramuscular injections
|
Yilmaz, Aylin
|
|
|
241 |
C |
p.
|
article
|
| 3 |
Cholesterol 25-hydroxylase inhibits Newcastle disease virus replication by its architectural damage and blocking HN protein
|
Nandy, Satyendu
|
|
|
241 |
C |
p.
|
article
|
| 4 |
Decreased CD4+ T cell counts drive aberrant B cell repertoire alterations in people living with HIV
|
Huang, Lina
|
|
|
241 |
C |
p.
|
article
|
| 5 |
Discovery of broad-spectrum antivirals targeting viral proteases using in silico structural modeling and cellular analysis
|
Patel, Dharmeshkumar
|
|
|
241 |
C |
p.
|
article
|
| 6 |
Editorial Board
|
|
|
|
241 |
C |
p.
|
article
|
| 7 |
Effect of antivirals on clinical and lab-adapted human cytomegalovirus strains using induced pluripotent stem cell-derived human neural models
|
Mulder, Lance A
|
|
|
241 |
C |
p.
|
article
|
| 8 |
Exploiting host kinases to combat dengue virus infection and disease
|
Bourgeois, Natasha M.
|
|
|
241 |
C |
p.
|
article
|
| 9 |
Farnesoid X receptor agonists as broad-acting antivirals: Evidence from hepatitis viruses and beyond?
|
Romain, Barnault
|
|
|
241 |
C |
p.
|
article
|
| 10 |
Functional characteristics of plitidepsin as an antiviral treatment against monkeypox virus infection
|
Albericio, Guillermo
|
|
|
241 |
C |
p.
|
article
|
| 11 |
Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling
|
Carter, Meghan F.
|
|
|
241 |
C |
p.
|
article
|
| 12 |
Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020–2023
|
Hussain, Saira
|
|
|
241 |
C |
p.
|
article
|
| 13 |
High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses
|
Vandemaele, Laura
|
|
|
241 |
C |
p.
|
article
|
| 14 |
Mammalian-targeted antiviral peptide reduces dengue virus type 1 infection in Aedes aegypti
|
Medina-Carrasco, Danya
|
|
|
241 |
C |
p.
|
article
|
| 15 |
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17–21, 2025
|
Jordan, Robert
|
|
|
241 |
C |
p.
|
article
|
| 16 |
Pralatrexate effectively inhibits the replication of monkeypox virus in vitro and in vivo
|
Li, Jianshu
|
|
|
241 |
C |
p.
|
article
|
| 17 |
SARS-CoV-2 neutralization and protection of hamsters via nasal administration of a humanized neutralizing antibody
|
Lebedin, Mikhail
|
|
|
241 |
C |
p.
|
article
|
| 18 |
Single-dose injection of human neutralizing antibody against ZIKV preserves male fertility and protects against lethal infection
|
Zhang, Hao
|
|
|
241 |
C |
p.
|
article
|
| 19 |
Suppression of herpes simplex virus type 1 replication by Pin1 inhibitors: insights from H-77 and novel compounds
|
Elsayed, Abeer Mohamed Abdelfattah
|
|
|
241 |
C |
p.
|
article
|
| 20 |
The protease inhibitor Nirmatrelvir synergizes with inhibitors of GRP78 to suppress SARS-CoV-2 replication
|
Al Krad, Doha
|
|
|
241 |
C |
p.
|
article
|
Journal description